0
Capricor Therapeutics, Inc. Banner Image

Capricor Therapeutics, Inc. has reached its limit for free report views

Work for Capricor Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Capricor Therapeutics, Inc.

  • Ticker CAPR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Capricor Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Los Angeles, California
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor’s lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy andMore COVID-19. Capricor is also investigating the field of extracellular vesicles and exploring the potential of exosome-based candidates to treat or prevent a variety of disorders.
Capricor Therapeutics, Inc.

Most Recent Annual Report

Capricor Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Capricor Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports